Curis | CRIS - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Alaunos Therapeutics USD 2.38M 172K 2026-03
Amgen USD 541M 1000K 2026-06
AstraZeneca USD 1.55B 44K 2026-06
Bayer EUR 982.42M 0 2026-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
CSL USD 482.13M 93.87M 2025-12
Curis USD 2M 10.93M 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Exelixis USD 248.88M 4.82M 2026-06
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
Incyte USD 200.98M 1.03M 2026-06
Merck USD 2.47B 4.93M 2026-03
Novartis USD 1.9B 7.38M 2026-06
Pfizer USD 5.7B 0 2026-06
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.21B 8.25M 2026-03
Takeda JPY 1.58B 460K 2026-06
TG Therapeutics USD 153.08M 2.23M 2026-06
Verastem USD 87.84M 10.1M 2026-03